keyword
https://read.qxmd.com/read/38491959/clinical-and-molecular-characterization-of-patients-with-ywhag-related-epilepsy
#21
JOURNAL ARTICLE
Valentina Cetica, Tiziana Pisano, Gaetan Lesca, Dana Marafi, Laura Licchetta, Florence Riccardi, Davide Mei, Hon-Yin B Chung, Allan Bayat, Meena Balasubramanian, Daniel H Lowenstein, Milda Endzinienė, Maha Alotaibi, Nathalie Villeneuve, Julia Jacobs, Bertrand Isidor, Roberta Solazzi, Nicolette S den Hollander, Dragan Marjanovic, Christelle Rougeot-Jung, Julien Jung, Marion Lesieur-Sebellin, Andrea Accogli, Vincenzo Salpietro, Nebal W Saadi, Eleni Panagiotakaki, Thomas Foiadelli, Sylvia Redon, Meng-Han Tsai, Francesca Bisulli, Trine B Hammer, James R Lupski, Elena Parrini, Renzo Guerrini
OBJECTIVE: YWHAG variant alleles have been associated with a rare disease trait whose clinical synopsis includes an early onset epileptic encephalopathy with predominantly myoclonic seizures, developmental delay/intellectual disability, and facial dysmorphisms. Through description of a large cohort, which doubles the number of reported patients, we further delineate the spectrum of YWHAG-related epilepsy. METHODS: We included in this study 24 patients, 21 new and three previously described, with pathogenic/likely pathogenic variants in YWHAG...
March 16, 2024: Epilepsia
https://read.qxmd.com/read/38490472/systematic-1%C3%A2-hz-direct-electrical-stimulation-for-seizure-induction-a-reliable-method-for-localizing-seizure-onset-zone-and-predicting-seizure-freedom
#22
JOURNAL ARTICLE
Adithya Sivaraju, Imran Quraishi, Evan Collins, Hari McGrath, Alexander Ramos, Nicholas B Turk-Browne, Hitten Zaveri, Eyiyemisi Damisah, Dennis D Spencer, Lawrence J Hirsch
OBJECTIVE: To prospectively investigate the utility of seizure induction using systematic 1Hz stimulation by exploring its concordance with the spontaneous seizure onset zone (SOZ) and relation to surgical outcome; comparison with seizures induced by non-systematic 50 Hz stimulation was attempted as well. METHODS: Prospective cohort study from 2018-2021 with ≥ 1y post-surgery follow up at Yale New Haven Hospital. With 1 Hz, all or most of the gray matter contacts were stimulated at 1, 5, and 10 mA for 30-60s...
March 13, 2024: Brain Stimulation
https://read.qxmd.com/read/38484965/chronic-evoked-seizures-in-young-pre-symptomatic-app-ps1-mice-induce-serotonin-changes-and-accelerate-onset-of-alzheimer-s-disease-related-neuropathology
#23
JOURNAL ARTICLE
Aaron Del Pozo, Kevin M Knox, Leanne M Lehmann, Stephanie Davidson, Seongheon Leo Rho, Suman Jayadev, Melissa Barker-Haliski
OBJECTIVE: Hyperexcitability is intimately linked to Alzheimer's disease (AD) pathology, but the precise timing and contributions of neuronal hyperexcitability to disease progression is unclear. Seizure induction in rodent AD models can uncover new therapeutic targets. Further, investigator-evoked seizures can directly establish how hyperexcitability and AD-associated risk factors influence neuropathological hallmarks and disease course at presymptomatic stages. METHODS: Corneal kindling is a well-characterized preclinical epilepsy model that allows for precise control of seizure history to pair to subsequent behavioral assessments...
March 12, 2024: Progress in Neurobiology
https://read.qxmd.com/read/38484613/cognitive-dysfunction-at-epilepsy-onset-as-a-marker-for-seizure-recurrence
#24
JOURNAL ARTICLE
Antonina Omisade, Madison Nugent, Christopher O'Grady, Kristin Ikeda, Stephanie Woodroffe, Karen Legg, Matthias Schmidt, Krista Biggs
BACKGROUND: Cognitive dysfunction has been correlated with seizure control in chronic epilepsy and in newly diagnosed epilepsy, which potentially makes it a good marker for predicting disease course and seizure control. However, there is a lack of prospective studies examining the role of cognitive dysfunction in predicting seizure recurrence at the earliest stages of the disease, such as following the first unprovoked seizure (UFS) or new onset epilepsy (NOE). METHODS: Thirty three adult participants (FS=18, NOE=15) from the Halifax First Seizure Clinic (HFSC) completed a cognitive screening assessment at baseline (typically 3 months following diagnosis); seizure-recurrence was evaluated one year after the initial HFSC visit...
February 28, 2024: Epilepsy Research
https://read.qxmd.com/read/38459409/foxg1-variants-can-be-associated-with-milder-phenotypes-than-congenital-rett-syndrome-with-unassisted-walking-and-language-development
#25
JOURNAL ARTICLE
Benoit Mazel, Julian Delanne, Aurore Garde, Caroline Racine, Ange-Line Bruel, Yannis Duffourd, Diego Lopergolo, Filippo Maria Santorelli, Viviana Marchi, Anna Maria Pinto, Maria Antonietta Mencarelli, Roberto Canitano, Floriana Valentino, Filomena Tiziana Papa, Chiara Fallerini, Francesca Mari, Alessandra Renieri, Arnold Munnich, Tanguy Niclass, Gwenaël Le Guyader, Christel Thauvin-Robinet, Christophe Philippe, Laurence Faivre
Since 2008, FOXG1 haploinsufficiency has been linked to a severe neurodevelopmental phenotype resembling Rett syndrome but with earlier onset. Most patients are unable to sit, walk, or speak. For years, FOXG1 sequencing was only prescribed in such severe cases, limiting insight into the full clinical spectrum associated with this gene. Next-generation sequencing (NGS) now enables unbiased diagnostics. Through the European Reference Network for Rare Malformation Syndromes, Intellectual and Other Neurodevelopmental Disorders, we gathered data from patients with heterozygous FOXG1 variants presenting a mild phenotype, defined as able to speak and walk independently...
March 8, 2024: American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics
https://read.qxmd.com/read/38446814/bifurcations-and-bursting-in-the-epileptor
#26
JOURNAL ARTICLE
Maria Luisa Saggio, Viktor Jirsa
The Epileptor is a phenomenological model for seizure activity that is used in a personalized large-scale brain modeling framework, the Virtual Epileptic Patient, with the aim of improving surgery outcomes for drug-resistant epileptic patients. Transitions between interictal and ictal states are modeled as bifurcations, enabling the definition of seizure classes in terms of onset/offset bifurcations. This establishes a taxonomy of seizures grounded in their essential underlying dynamics and the Epileptor replicates the activity of the most common class, as observed in patients with focal epilepsy, which is characterized by square-wave bursting properties...
March 6, 2024: PLoS Computational Biology
https://read.qxmd.com/read/38443004/comparative-analysis-of-hemispherotomy-in-adults-versus-children-a-prospective-observational-series
#27
JOURNAL ARTICLE
Jitin Bajaj, Sarat P Chandra, Bhargavi Ramanujam, Heri Subianto, Shabari Girishan, Ramesh Doddamani, Mohit Agrawal, Raghu Samala, Rekha Dwivedi, Kapil Chaudhary, Ajay Garg, Madhavi Tripathi, C S Bal, Ashima Nehra, Mehar C Sharma, Manjari Tripathi
BACKGROUND: Hemispherotomy (HS) is an effective treatment for unilateral hemispheric onset epilepsy. There are few publications for HS in adults, and there is no series comparing adults and pediatric patients of HS. OBJECTIVE: To compare the hemispherotomies done in adult patients with pediatric ones in terms of efficacy and safety. METHODS: Data was prospectively collected for HS patients (up to 18 years and more) from Aug 2014 to Aug 2018...
January 1, 2024: Neurology India
https://read.qxmd.com/read/38441162/status-epilepticus-what-s-new-for-the-intensivist
#28
JOURNAL ARTICLE
Sarah Benghanem, Estelle Pruvost Robieux, Aidan Neligan, Matthew C Walker
PURPOSE OF REVIEW: Status epilepticus (SE) is a common neurologic emergency affecting about 36.1/100 000 person-years that frequently requires intensive care unit (ICU) admission. There have been advances in our understanding of epidemiology, pathophysiology, and EEG monitoring of SE, and there have been large-scale treatment trials, discussed in this review. RECENT FINDINGS: Recent changes in the definitions of SE have helped guide management protocols and we have much better predictors of outcome...
February 14, 2024: Current Opinion in Critical Care
https://read.qxmd.com/read/38433525/the-latest-advances-in-the-pharmacological-management-of-focal-epilepsies-in-children-a-narrative-review
#29
REVIEW
Sara Matricardi, Giovanna Scorrano, Giovanni Prezioso, Beatrice Burchiani, Giuseppe Di Cara, Pasquale Striano, Francesco Chiarelli, Alberto Verrotti
INTRODUCTION: Focal epilepsy constitutes the most common epilepsy in children, and medical treatment represents the first-line therapy in this condition. The main goal of medical treatment for children and adolescents with epilepsy is the achievement of seizure freedom or, in drug-resistant epilepsies, a significant seizure reduction, both minimizing antiseizure medications (ASM)-related adverse events, thus improving the patient's quality of life. However, up to 20-40% of pediatric epilepsies are refractory to drug treatments...
April 2024: Expert Review of Neurotherapeutics
https://read.qxmd.com/read/38430119/second-line-immunotherapy-in-new-onset-refractory-status-epilepticus
#30
REVIEW
Aurélie Hanin, Eyal Muscal, Lawrence J Hirsch
Several pieces of evidence suggest immune dysregulation could trigger the onset and modulate sequelae of new onset refractory status epilepticus (NORSE), including its subtype with prior fever known as febrile infection-related epilepsy syndrome (FIRES). Consensus-driven recommendations have been established to guide the initiation of first- and second-line immunotherapies in these patients. Here, we review the literature to date on second-line immunotherapy for NORSE/FIRES, presenting results from 28 case reports and series describing the use of anakinra, tocilizumab, or intrathecal dexamethasone in 75 patients with NORSE...
March 2, 2024: Epilepsia
https://read.qxmd.com/read/38410154/mecp2-related-disorders-while-gene-based-therapies-are-on-the-horizon
#31
REVIEW
Katherine Allison, Mirjana Maletic-Savatic, Davut Pehlivan
The emergence of new genetic tools has led to the discovery of the genetic bases of many intellectual and developmental disabilities. This creates exciting opportunities for research and treatment development, and a few genetic disorders (e.g., spinal muscular atrophy) have recently been treated with gene-based therapies. MECP2 is found on the X chromosome and regulates the transcription of thousands of genes. Loss of MECP2 gene product leads to Rett Syndrome, a disease found primarily in females, and is characterized by developmental regression, motor dysfunction, midline hand stereotypies, autonomic nervous system dysfunction, epilepsy, scoliosis, and autistic-like behavior...
2024: Frontiers in Genetics
https://read.qxmd.com/read/38400813/pharmacokinetics-of-staccato-%C3%A2-alprazolam-in-healthy-adult-participants-in-two-phase-1-studies-an-open-label-smoker-study-and-a-randomized-placebo-controlled-ethnobridging-study
#32
JOURNAL ARTICLE
Yoshinobu Hayakawa, Chiara Rospo, Ana Paula Bartmann, Aliceson King, Robert Roebling, Hugues Chanteux
OBJECTIVE: Staccato® alprazolam is a single-use, drug-device combination delivering alprazolam to the deep lung that is being evaluated as treatment for rapid and early seizure termination. This article reports pharmacokinetic (PK) data from two phase 1 studies of Staccato alprazolam in healthy adult participants. METHODS: The smoker study (EPK-002/NCT03516305) was an open-label, nonrandomized, single-dose, PK study in smokers and nonsmokers aged 21-50 years, administered a single inhaled dose of 1 mg Staccato alprazolam...
February 24, 2024: Epilepsia
https://read.qxmd.com/read/38398636/quantitative-analysis-of-cenobamate-and-concomitant-anti-seizure-medications-in-human-plasma-via-ultra-high-performance-liquid-chromatography-tandem-mass-spectrometry
#33
JOURNAL ARTICLE
Linda Molteni, Bruno Charlier, Albino Coglianese, Viviana Izzo, Giovanni Assenza, Pierantonio Menna, Ugo de Grazia, Annachiara D'Urso
Cenobamate (CNB) is a new anti-seizure medication (ASM) recently introduced in clinical practice after approval by the FDA and EMA for the add-on treatment of focal onset seizures in adult patients. Although its mechanism of action has not been fully understood, CNB showed promising clinical efficacy in patients treated with concomitant ASMs. The accessibility of CNB could pave a way for the treatment of refractory or drug-resistant epilepsies, which still affect at least one-third of the patients under pharmacological treatment...
February 17, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/38366961/long-term-outcomes-after-new-onset-seizure-in-children-living-with-hiv-a-cohort-study
#34
JOURNAL ARTICLE
Gretchen L Birbeck, Musaku Mwenechanya, Ifunanya Ume-Ezeoke, Manoj Mathews, Christopher M Bositis, Lisa Kalungwana, David Bearden, Melissa Elafros, Harris A Gelbard, William H Theodore, Igor J Koralnik, Jason F Okulicz, Brent A Johnson, Namwiya Musonda, Omar K Siddiqi, Michael J Potchen, Izukanji Sikazwe
OBJECTIVE: To determine the long-term outcomes, including mortality and recurrent seizures, among children living with HIV (CLWH) who present with new onset seizure. METHODS: Zambian CLWH and new onset seizure were enrolled prospectively to determine the risk of and risk factors for recurrent seizures. Demographic data, clinical profiles, index seizure etiology, and 30-day mortality outcomes were previously reported. After discharge, children were followed quarterly to identify recurrent seizures and death...
February 17, 2024: Epilepsia Open
https://read.qxmd.com/read/38350362/cognitive-development-in-children-with-new-onset-rolandic-epilepsy-and-rolandic-discharges-without-seizures-focusing-on-intelligence-visual-perception-working-memory-and-the-role-of-parents-education
#35
JOURNAL ARTICLE
Helmut Neumann, Monika Daseking, Charlotte Thiels, Cornelia Köhler, Thomas Lücke
PURPOSE: Our aim was to assess intelligence, visual perception and working memory in children with new-onset Rolandic epilepsy (RE) and children with Rolandic discharges without seizures (RD). METHODS: The participants in the study were 12 children with RE and 26 children with RD aged 4 to 10 years (all without medication and shortly after diagnosis) and 31 healthy controls. Their cognitive performance was assessed using the German versions of the Wechsler Preschool and Primary Scale of Intelligence (WPPSI-III), the Wechsler Intelligence Scale for Children (WISC-IV), the Developmental Test of Visual Perception-2 (DTVP-2), the Developmental Test of Visual Perception-Adolescent and Adult (DTVP-A) (each according to age) and the Word Order, Hand Movements and Spatial Memory subtests of the German version of the Kaufman Assessment Battery for Children (K-ABC)...
February 12, 2024: Epilepsy & Behavior: E&B
https://read.qxmd.com/read/38337154/homozygous-variant-of-mlc1-results-in-megalencephalic-leukoencephalopathy-with-subcortical-cysts
#36
JOURNAL ARTICLE
Jian Zha, Yong Chen, Fangfang Cao, Yuxin Xu, Zuozhen Yang, Shu Wen, Mengmeng Liang, Huaping Wu, Jianmin Zhong
BACKGROUND: Megalencephalic leukoencephalopathy with subcortical cysts (MLC) is a rare, inherited disorder that causes epilepsy, intellectual disorders, and early onset macrocephaly. MLC1 has been identified as a main pathogenic gene. METHODS: Clinical data such as magnetic resonance imaging (MRI), routine blood tests, and physical examinations were collected from proband. Trio whole-exome sequencing (WES) of the family was performed, and all variants with a minor allele frequency (<0...
February 2024: Molecular Genetics & Genomic Medicine
https://read.qxmd.com/read/38333287/successfully-treated-anti-gad-limbic-encephalitis-in-a-15-year-old-diabetic-boy-with-intravenous-immunoglobulin-case-report
#37
Ghassem Fattahzadeh Ardalani, Ali Samady Khanghah, Mohammad Jahanpanah, Diana Mokhtari, Parisa Samady Khanghah
INTRODUCTION AND IMPORTANCE: Limbic encephalitides (LE) have symptoms and signs of new-onset seizures accompanied by cognitive impairment and signal changes in the MRI of the limbic system in the brain. Numerous antibodies against the neurons and synapses have been detected so far. Of those, antiglutamic acid decarboxylase antibody (Anti-GAD Ab) impairs the gamma amino butyric acid, one of the primary mediators that naturally prevents abnormal neuronal activity causing seizure. CASE PRESENTATION: The authors have reported a case of anti-GAD Ab LE in a diabetic male adolescent who responded dramatically to intravenous immunoglobulin and reviewed all similar pediatric cases for 15 years now...
February 2024: Annals of Medicine and Surgery
https://read.qxmd.com/read/38330780/time-to-fire-norse-a-single-acronym-for-a-heterogeneous-presentation-further-information-from-a-case-series-and-discussion-of-the-literature
#38
JOURNAL ARTICLE
Abdulaziz M Alaskar, Majed A Aljohani, Sasha Dionisio, Mohammed A Asiry, Khalid Alqadi
PURPOSE: New-Onset Refractory Status Epilepticus (NORSE) is a rare and severe form of refractory status epilepticus without an apparent underlying cause at presentation or prior history of epilepsy. We aimed to describe the clinical features, etiology, treatment, and outcomes of NORSE in adults in a quaternary-level hospital in Saudi Arabia. METHODOLOGY: In this retrospective cohort study, inclusion criteria involved patients over 14 years old who met the 2018 consensus definition for NORSE...
March 15, 2024: Journal of Neuroimmunology
https://read.qxmd.com/read/38324990/neurodevelopmental-outcome-of-neonatal-seizures-a-longitudinal-study
#39
JOURNAL ARTICLE
Licia Lugli, Maria Carolina Bariola, Isotta Guidotti, Marisa Pugliese, Maria Federica Roversi, Luca Bedetti, Elisa Della Casa Muttini, Francesca Miselli, Luca Ori, Laura Lucaccioni, Natascia Bertoncelli, Katia Rossi, Sara Crestani, Patrizia Bergonzini, Lorenzo Iughetti, Fabrizio Ferrari, Alberto Berardi
INTRODUCTION: Neonatal seizures (NS) are the most common neurological emergency in the neonatal period. The International League Against Epilepsy (ILAE) proposed a new classification of NS based on semiology and highlighted the correlation between semiology and aetiology. However, neurodevelopmental outcomes have not been comprehensively evaluated based on this new classification. AIMS: To evaluate neurodevelopmental outcomes and potential risk factors for severe outcomes in NS...
January 28, 2024: European Journal of Paediatric Neurology: EJPN
https://read.qxmd.com/read/38319041/cognitive-and-psychological-dysfunction-is-present-after-a-first-seizure-prior-to-epilepsy-diagnosis-and-treatment-at-a-first-seizure-clinic
#40
JOURNAL ARTICLE
Remy Pugh, David N Vaughan, Graeme D Jackson, Jennie Ponsford, Chris Tailby
OBJECTIVE: Neuropsychological comorbidities found in chronic epilepsy have also been reported earlier in the disease course. However, recurrent seizures, antiseizure medication (ASM), and adjustment to a chronic diagnosis remain potential confounds of this literature. It thus remains unclear whether these comorbidities are primary or secondary attributes of epilepsy. To capture individuals as close to disease onset as possible, we studied the cognitive and psychological functioning in adults after their first seizure, yet prior to epilepsy diagnosis and treatment...
February 6, 2024: Epilepsia Open
keyword
keyword
97515
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.